Lilly and Boehringer Ingelheim will now be able to promote their drug Jardiance in the US as a way for diabetes patients ... death risk by 38%. An oral SGLT2 inhibitor, Jardiance (empagliflozin ...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus their energies on developing their big-selling Jardiance pill. Under the terms of the original ...